• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Enteric Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019 Product Image

Enteric Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

  • ID: 2668498
  • September 2013
  • Region: Global
  • 92 Pages
  • Transparency Market Research

FEATURED COMPANIES

  • Alere, Inc
  • Biomerica, Inc
  • Biomerieux
  • Bio-Rad
  • Cepheid
  • Coris Bioconcept
  • MORE

'Enteric Disease Testing Market (Amebiasis, C.Difficile Infection, Campylobacteriosis, Cholera, Cryptosporidiosis, E.Coli Infection, Giardiasis, H.Pylori Infection, Norovirus Infection, Rotavirus Infection, Salmonellosis And Shigellosis) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019'

Infectious enteric diseases are usually caused by a variety of bacteria, viruses and parasites when they enter the body through the mouth and intestinal tract, primarily as a result of ingesting contaminated food and liquids. This study analyzes the enteric disease testing market for 12 major types that include campylobacteriosis, salmonellosis, giardiasis, cryptosporidiosis, amebiasis, norovirus infection and clostridium difficile mediated infection.

The market accounts for a wide range of conventional as well as rapid diagnostic kits used for the identification of these diseases. The report also details the types of rapid tests and the technologies they work on, such as rapid dipstick and rapid test cassette. The report also explains the reasons for the paradigm shift from culture tests to rapid tests.

On the basis of geography, the market is classified READ MORE >

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Alere, Inc
  • Biomerica, Inc
  • Biomerieux
  • Bio-Rad
  • Cepheid
  • Coris Bioconcept
  • MORE

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation: Enteric Disease Testing
1.3 Research Methodology
1.3.1 Sources
1.3.1.1 Secondary Research
1.3.1.2 Primary Research
1.4 Assumptions And Intimations

Chapter 2 Executive Summary
2.1 Market Introduction
2.2 Comparison Analysis By Geography: Enteric Disease Testing Market (2012 & 2019)

Chapter 3 Enteric Disease Testing Market Overview
3.1 Enteric Diseases
3.2 Rise of Rapid Testing for Enteric Diseases
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.1 Demand for Rapid Diagnosis
3.3.1.2 Untapped Market in Developing Countries
3.3.1.3 Application of Molecular Diagnostics
3.3.2 Restraints
3.3.2.1 Lack of Awareness
3.3.2.2 Mild and Asymptomatic Diseases
3.3.3 Opportunities
3.3.3.1 Increasing Opportunities in Molecular Diagnostics Based Enteric Disease Testing
3.3.3.2 Developing Nations will be Highly Lucrative Markets
3.4 Porters Five Forces Analysis for Global Enteric Disease Testing Market
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Threat from Substitutes
3.4.4 Threat from New Entrants
3.4.5 Degree of Competitive Rivalry
3.5 Market Attractiveness for Enteric Disease Testing Market, By Geography, 2012

Chapter 4 Global Enteric Disease Testing Market
4.1 Bacterial Enteric Disease Testing Market
4.1.1 Clostridium Difficile Infection
4.1.1.1 Epidemiology
4.1.1.2 Diagnostic Tests and Market Overview
4.1.2 Campylobacteriosis
4.1.2.1 Epidemiology
4.1.2.2 Diagnostic Tests and Market Overview
4.1.3 Cholera
4.1.3.1 Epidemiology
4.1.3.2 Diagnostic Tests and Market Overview
4.1.4 E.Coli Enteric Diseases
4.1.4.1 Epidemiology
4.1.4.2 Diagnostic Tests and Market Overview
4.1.5 Helicobacter Pylori Enteric Diseases
4.1.5.1 Epidemiology
4.1.5.2 Diagnostic Tests and Market Overview
4.1.6 Salmonellosis
4.1.6.1 Epidemiology
4.1.6.2 Diagnostic Tests and Market Overview
4.1.7 Shigellosis
4.1.7.1 Epidemiology
4.1.7.2 Diagnostic Tests and Market Overview
4.2 Viral Enteric Disease Testing Market
4.2.1 Rotavirus
4.2.1.1 Epidemiology
4.2.1.2 Diagnostic Tests and Market Overview
4.2.2 Norovirus Enteric Disease Testing
4.2.2.1 Epidemiology
4.2.2.2 Diagnostic Tests and Market Overview
4.3 Parasitic Enteric Disease Testing Market
4.3.1 Amebiasis
4.3.1.1 Epidemiology
4.3.1.2 Diagnostic Tests and Market Overview
4.3.2 Cryptosporidiosis
4.3.2.1 Epidemiology
4.3.2.2 Diagnostic Tests and Market Overview
4.3.3 Giardiasis
4.3.3.1 Epidemiology
4.3.3.2 Diagnostic Tests and Market Overview

Chapter 5 Global Enteric Disease Testing Market, By Geography, 2011 - 2019 (USD Million)
5.1 Introduction
5.1.1 North America
5.1.1.1 North America Enteric Disease Testing Market, By Types of Diseases, 2011 - 2019 (USD Million)
5.1.2 Europe
5.1.2.1 Europe Enteric Disease Testing Market, By Types of Diseases, 2011 - 2019 (USD Million)
5.1.3 Asia-Pacific
5.1.3.1 Asia-Pacific Enteric Disease Testing Market, By Types of Diseases, 2011 - 2019 (USD Million)
5.1.4 Africa
5.1.4.1 Africa Enteric Disease Testing Market, By Types of Diseases, 2011 - 2019 (USD Million)
5.1.5 Latin America
5.1.5.1 Latin America Enteric Disease Testing Market, By Types of Diseases, 2011 - 2019 (USD Million)
5.1.6 Rest Of The World
5.1.6.1 Rest of the World Enteric Disease Testing Market, By Types of Diseases, 2011 - 2019 (USD Million)

Chapter 6 Key Player Analysis for Enteric Disease Testing Market, 2012

Chapter 7 Company Profiles
7.1 Alere, Inc.
7.1.1 Company Overview
7.1.2 Financial Overview
7.1.3 Product Portfolio
7.1.4 Business Strategies
7.1.5 Recent Developments
7.2 Becton Dickinson & Company
7.2.1 Company Overview
7.2.2 Financial Overview
7.2.3 Product Portfolio
7.2.4 Business Strategies
7.2.5 Recent Developments
7.3 Biomerica, Inc.
7.3.1 Company Overview
7.3.2 Financial Overview
7.3.3 Product Portfolio
7.3.4 Recent Developments
7.4 Biomerieux
7.4.1 Company Overview
7.4.2 Financial Overview
7.4.3 Product Portfolio
7.4.4 Business Strategies
7.4.5 Recent Developments
7.5 Bio-Rad
7.5.1 Company Overview
7.5.2 Financial Overview
7.5.3 Product Portfolio
7.5.4 Business Strategies
7.6 Cepheid
7.6.1 Company Overview
7.6.2 Financial Overview
7.6.3 Product Portfolio
7.6.4 Business Strategies
7.6.5 Recent Developments
7.7 Coris Bioconcept
7.7.1 Company Overview
7.7.2 Financial Overview
7.7.3 Product Portfolio
7.7.4 Recent Developments
7.8 Diasorin
7.8.1 Company Overview
7.8.2 Financial Overview
7.8.3 Product Portfolio
7.8.4 Business Strategies
7.8.5 Recent Developments
7.9 Meridian Bioscience, Inc.
7.9.1 Company Overview
7.9.2 Financial Overview
7.9.3 Product Portfolio
7.9.4 Business Strategies
7.9.5 Recent Developments
7.10 Quest Diagnostics
7.10.1 Company Overview
7.10.2 Financial Overview
7.10.3 Product Portfolio
7.10.4 Business Strategies
7.10.5 Recent Developments
7.11 Trinity Biotech
7.11.1 Company Overview
7.11.2 Financial Overview
7.11.3 Product Portfolio
7.11.4 Business Strategies
7.11.5 Recent Developments

List of Figures

FIG. 1 Market Segmentation: Enteric Disease Testing
FIG. 2 Comparison Analysis, By Geography (2012 & 2019) Enteric Disease Testing Market
FIG. 3 Porter's Five Forces Analysis For Global Enteric Disease Testing Market
FIG. 4 Market Attractiveness For Enteric Disease Testing Market, By Geography, 2012
FIG. 5 Global Bacterial Enteric Disease Testing Market, By Disease Type, 2011 - 2019 (USD Million)
FIG. 6 Global Viral Enteric Disease Testing Market, By Disease Type, 2011 - 2019 (USD Million)
FIG. 7 Global Parasitic Enteric Disease Testing Market, 2011-2019 (USD Million)
FIG. 8 Alere: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 9 Becton Dickinson: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 10 Biomerica, Inc.: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 11 Biomerieux: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 12 Bio-Rad: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 13 Cepheid: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 14 Diasorin: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 15 Meridian Bioscience, Inc.: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 16 Quest Diagnostics: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 17 Trinity Biotech: Annual Sales Revenue, USD Million, 2010 – 2012

List of Tables

TABLE 1 Market Snapshot: Enteric Disease Testing Products
TABLE 2 Global Enteric Disease Testing Market, By Types of Diseases, 2011 - 2019 (USD Million)
TABLE 3 Global C.Difficile Infection Testing Market, By Geography, 2011 - 2019 (USD Million)
TABLE 4 Global Campylobacteriosis Testing Market, By Geography, 2011 - 2019 (USD Million)
TABLE 5 Global Cholera Testing Market, By Geography, 2011 - 2019 (USD Million)
TABLE 6 Global E.Coli Infection Testing Market, By Geography, 2011 - 2019 (USD Million)
TABLE 7 Global H.Pylori Infection Testing Market, By Geography, 2011 - 2019 (USD Million)
TABLE 8 Global Salmonellosis Testing Market, By Geography, 2011 - 2019 (USD Million)
TABLE 9 Global Shigellosis Testing Market, By Geography, 2011 - 2019 (USD Million)
TABLE 10 Global Rotavirus Infection Testing Market, By Geography, 2011 - 2019 (USD Million)
TABLE 11 Global Norovirus Infection Testing Market, By Geography, 2011 - 2019 (USD Million)
TABLE 12 Global Amebiasis Testing Market, By Geography, 2011 - 2019 (USD Million)
TABLE 13 Global Cryptosporidiosis Testing Market, By Geography, 2011 - 2019 (USD Million)
TABLE 14 Global Giardiasis Testing Market, By Geography, 2011 - 2019 (USD Million)
TABLE 15 North America Enteric Disease Testing Market, By Types Of Diseases, 2011 - 2019 (USD Million)
TABLE 16 Europe Enteric Disease Testing Market, By Types Of Diseases, 2011 - 2019 (USD Million)
TABLE 17 Asia-Pacific Enteric Disease Testing Market, By Types Of Diseases, 2011 - 2019 (USD Million)
TABLE 18 Africa Enteric Disease Testing Market, By Types Of Diseases, 2011 - 2019 (USD Million)
TABLE 19 Latin America Enteric Disease Testing Market, By Types Of Diseases, 2011 - 2019 (USD Million)
TABLE 20 Rest of the World Enteric Disease Testing Market, By Types Of Diseases, 2011 - 2019 (USD Million)

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Alere, Inc
  • Biomerica, Inc
  • Biomerieux
  • Bio-Rad
  • Cepheid
  • Coris Bioconcept
  • MORE

Enteric diseases are gastrointestinal infections caused by a variety of microbes such as bacteria, viruses and parasites when they enter the body through the mouth or intestinal systems. Various microbes responsible for enteric infections include salmonella, shigella, rotavirus, norovirus, c. difficile, cryptosporidium, vibrio and campylobacter. These diseases may range from asymptomatic to having mild to severe symptoms such as bloody diarrhea, abdominal cramps, stool containing blood or pus, fever and weight loss. Incubation period varies from few days to few weeks depending on the disease and severity. In order to reduce the chance of developing complications, these diseases needed to be diagnosed early.

The market for the enteric disease testing market has been segmented on the basis of different types of enteric diseases and their testing. Earlier, diagnosis of enteric diseases relied on culture results of stool specimen that involved identification of causative pathogens in a culture medium. However, the trend is now shifting from culture methods to other diagnostic methods owing to limitations associated with culture tests. Major drawbacks associated with culture tests include high cost, labor intensive, requires sophisticated laboratory and a skilled person to perform the diagnosis. On the other hand, enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction (PCR) has made enteric infection diagnosis easy and fast. In developed regions such as North America and Europe, PCR based diagnosis is most recommended testing method for enteric diseases as it offers high sensitivity and specificity and is considered as easy, accurate, rapid and reliable method of diagnosis. Latest introductions in MALDI-TOF have also been developed for rapid diagnosis of whole organisms without destruction of infection sample.

Asia-Pacific accounting for more than 50% of the total global population represents the most profitable market for enteric disease testing in terms of growth and potential. The region associated with unsafe drinking water, poor sanitation and unhygienic condition contained a large percentage of population infected with enteric microbes. The market for enteric disease testing is primarily driven in this region due to high prevalence of enteric infections, rising awareness, inception of rapid diagnostic tests and continuously improving economy of India and China leading to increased healthcare expenditure. Rapid dipstick test kit based on lateral flow technology is expected to experience a rapid growth in Asia-Pacific as these kits being inexpensive, easy to perform and enabling quick results. Japan, Australia and New Zealand being economically stable are expected to witness market growth because of molecular diagnostic based tests such as EIA and PCR. As most of the enteric diseases are more susceptible to children and elderly people, the market for enteric disease testing in Japan is growing due to large proportion of people aged over 65 years.

The global market for enteric disease testing is expected to reach USD 3,643.4 million by 2019, up from USD 3,082.6 million in 2012, growing at a CAGR of 2.4% throughout the forecast period. Geographically, North America represents the largest market because of high cost of products and high level of consumer awareness. DiaSorin, Cepheid, Alere, Biomerica and Meridian Bioscience are some of the vendors operating in this market.

Note: Product cover images may vary from those shown

- Alere, Inc
- Becton Dickinson & Company
- Biomerica, Inc
- Biomerieux
- Bio-Rad
- Cepheid
- Coris Bioconcept
- Diasorin
- Meridian Bioscience, Inc
- Quest Diagnostics
- Trinity Biotech

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos